사용자 삽입 이미지
 
 








교육 및 임상 경력

1993 - 1999  연세의대
1999 - 2002  공중보건의
2003 - 2007  신촌세브란스 전공의
2008 - 2010  신촌세브란스 강사
2011 - 2012  신촌세브란스 임상조교수
2013 - 2015  신촌세브란스 임상조교수
2016 - 현재  신촌세브란스 부교수
  

학술관련경력

대한내과학회 회원

대한소화기학회 회원 (2013~현재: 편집위원)

대한간학회 회원 (2012~2013: 홍보위원; 2014~2015: 학술위원)

대한간암학회 회원 (2014~2015: 학술위원)

대한방사선색전술 학회 회원
    

학력사항

2004 - 2006  연세의대 의학대학원 석사
2008 - 2014  연세의대 의학대학원 박사 


REVIEWS
1.     KH Han, SU Kim (Co-primary). Liver stiffness measurement using FibroScan®. The Korean Journal of Internal Medicine 2008; 74: 463-471.

2.     SU Kim. Topics related to liver fibrosis (Summary of AASLD 2009, Boston, USA). The Korean Journal of Hepatology. 2009.

3.
     SU Kim, KH Han, SH Ahn. Transient elastography in chronic hepatitis B: an Asian perspective. World Journal of Gastroenterology 2010; 16: 5173-5180.

4.
     KS Jung, SU Kim (Corresponding). Clinical application of transient elastography. Clinical and Molecular Hepatology 2012; 18: 1-10.

5.     BY Kim, KH Han, SU Kim (Corresponding). Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from a longitudinal perspective. World Journal of Gastroenterology 2013; 19: 1890-1900.

6.     SU Kim, BK Kim, KH Han. Clinical application of liver stiffness measurement using transient elastography: a surgical perspective. Digestion 2013;88:258-265.

7.     JH Kim, MN Kim, KH Han, SU Kim (Corresponding). Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment. Liver Int 2015; 35: 1103-1115.

8.     MS Park, KH Han, SU Kim (Corresponding). Non-invasive prediction of development of hepatocellular carcinoma using transient elastography in patients with chronic liver disease. Expert Rev Gastroenterol Hepatol 2014; 8: 501-511.

9.     Kim MN, Kim BK, Han KH, Kim SU (Corresponding). Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma: consideration for tumor response assessment. Expert Rev Gastroenterol Hepatol 2014; 5: 1-14.

10. Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia. J Hepatol 2017

LETTERS

1.     SM Lim, MJ Chung, KH Han, SU Kim (Corresponding). Acoustic radiation force impulse elastography: a better option for patients with extrahepatic cholestasis. European Journal of Gastroenterology and Hepatology. 2012; 24: 215-216.

2.
     SM Lim, SU Kim (Corresponding). Acoustic radiation force impulse elastography is useful to exclude nonliver-related ascites. European Journal of Gastroenterology and Hepatology. 2011; 23: 1080-1081. 

3.     Y Park, SU Kim (Corresponding), MJ Koh, S Lee. Compensated heart failure does not always alleviate overestimation of liver stiffness by transient elastography. European Journal of Gastroenterology and Hepatology 2013; 25: 385-387.

4.     EH Kim, BK Kim, DY Kim, SU Kim (Corresponding). Optimal timing of combining sorafenib with locoregional treatments in patients with advanced hepatocellular carcinoma. European Journal of Gastroenterology and Hepatology 2013; 25: 514-515.

EDITORIALS

1.
   SU Kim, KH Han, SH Ahn. Non-invasive assessment of liver fibrosis: the gap between ideal and real. Journal of Gastroenterology and Hepatology. 2011; 26: 937-939.

2.   SU Kim, KH Han, SH Ahn. Non-invasive assessment of liver fibrosis: time to move from cross-sectional studies to longitudinal ones. J Gastroenterology and Hepatology 2010; 25: 1472-1473.
 
3.  V. Leroy, SU Kim (Corresponding). Can transient elastography be used for the management of chronic hepatitis B patients? Liver International. 2012; 32: 528-530.

4. 
YE Chon, SU Kim, SH Ahn. Transient elastography in real practice: A time for action? Journal of Gastroenterology and Hepatology. 2012; 27: 1134-1135.

5.
   W Kang, SU Kim (Corresponding). Chasing after novel non-invasive markers to identify advanced fibrosis in NAFLD. Clin Mol Hepatol 2013; 19: 255-257.

6. SU Kim. Can  magnetic resonance elastography fill a niche in the marker for noninvasive assessment of liver fibrosis? Gut Liver; 11:321-322.

CASE REPORT

1. Ahn SS, Kim EH, Kim MD, Lee WJ, Kim SU(Corresponding). Successful hemostasis of intractable rectal variceal bleeding using variceal embolization. World J Gastroenterol 2015; 28: 2558-2562.

ORIGINAL ARTICLES, PUBLISHED
[International]

1.   SU Kim, JY Park, WS Kang, DY Kim, YH Paik, KW Lee, BK Kim, BS Kim, YN Park, CY Chon, KH Han, SH Ahn. Liver stiffness measurement in combination with simple non-invasive markers for improved diagnosis of B-viral liver cirrhosis. Journal of Clinical Gastroenterology 2009; 43: 267-271.

2.  SU Kim, KH Han, JY Park, SH Ahn, MJ Chung, CY Chon, EH Choi, DY Kim. Liver stiffness measurement using FibroScan® is influenced by serum total bilirubin in acute hepatitis. Liver international 2009; 29: 810-815.

3.  DY Kim, SU Kim (Co-primary), SH Ahn, JY Park, JM Lee, YN Park, KT Yoon, YH Paik, KS Lee, CY Chon, KH Han. The usefulness of liver stiffness measurement for the detection of early compensated liver cirrhosis on chronic hepatitis B patients. Digestive Diseases and Sciences 2009; 54: 1758-1763.

4.  SU Kim, SH Ahn, JY Park, DY Kim, CY Chon, JS Choi, KS Kim, KH Han. Prediction of postoperative hepatic insufficiency by liver stiffness measurement before curative resection of hepatocellular carcinoma: A pilot study. epatology International 2008; 2: 471-477.

5
SU Kim, CM Nam, KH Han, JY Park, DY Kim, BS Moon, CY Chon, YM Moon, SH Ahn. The natural history of HBV-related cirrhotic patients hospitalized to control ascites. Journal of Gastroenterology and Hepatology 2008; 23: 1722-1727.

6.  SU Kim, DY Kim, SH Ahn, HJ Nah, CY Chon, KH Han. Hepatocellular carcinoma presenting as bone metastasis. Journal of Cancer Research and Clinical Oncology 2008; 134: 1377-1384.

7.  SU Kim, JK Kim, JY Park, SH Ahn, JM Lee, Oidov Baatarkhuu, EH choi, KH Han, CY Chon, DY Kim. Variability of liver stiffness values from different intercostal spaces. Liver International 2009; 28: 760-766.

8.  DY Kim, SH Ahn, HW Lee, JY Park, SU Kim, YH Paik, KS Lee, KH Han, CY Chon. Clinical course of virologic breakthrough after emergence of YMDD mutations in HBeAg-positive chronic hepatitis B. Intervirology 2008; 51: 293-298.

9.  DY Kim, SH Ahn, HW Lee, SU Kim, JK Kim, YH Paik, KS Lee, KH Han, CY Chon. Anti-hepatitis A virus seroprevalence among patients with chronic viral liver disease in Korea. European Journal of Gastroenterology and Hepatology 2007; 19: 923-926.

10. 
 SU Kim, DY Kim, JY Park, JM Lee, SH Ahn, JK Kim, YH Paik, KS Lee, CY Chon, EH Choi, KJ Song, YN Park, KH Han. How can we enhance the performance of liver stiffness measurement using FibroScan in diagnosing liver cirrhosis in patients with chronic hepatitis B. Journal of Clinical Gastroenterology 2010; 44: 66-71.

11. 
 SU Kim, DY Kim, CK Lee, JY Park, SH Kim, HM Kim, EH Choi, S Kim, KH Han, CY Chon. Ascitic fluid infection in patients with hepatitis B virus-related liver cirrhosis: culture-negative neutrocytic ascites versus spontaneous bacterial peritonitis. Journal of Gastroenterology and Hepatology 2010; 25: 122-128.

12. 
 SU Kim, DY Kim, SH Ahn, HM Kim, JM Lee, CY Chon, YN Park, KH Han, JY Park. The impact of steatosis on liver stiffness measurement in patients with chronic hepatitis B. Hepatogastoenterology 2010; 57: 832-838.

13. 
 SU Kim, GH Choi, WK Han, BK Kim, JY Park, DY Kim, JS Choi, SC Yang, EH Choi, SH Ahn, KH Han, CY Chon. What are “true normal” liver stiffness values using FibroScan®?: A prospective study in healthy living liver and kidney donors in South Korea. Liver International 2009; 30: 268-274.

14.  SU Kim, JY Park, DY Kim, SH Ahn, EH Choi, JY Seok, JM Lee, YN Park, CY Chon, KH Han. Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: Impact of antiviral treatment on fibrosis regression. Hepatology Int 2010; 4: 673-680.

15.
 SU Kim, YC Kim, JS Choi, KS Kim, GH Choi, JS Choi, JY Park, DY Kim, SH Ahn, EH Choi, YN Park, CY Chon, KH Han, MJ Kim. Can preoperative diffusion-weighted MRI predict postoperative hepatic insufficiency after curative resection of HBV-related hepatocellular carcinoma?: a pilot study. MRI 2010; 28: 802-811.

16.   MJ Chung, JH Cheon, SU Kim, JJ Park, TI Kim, NK Kim, WH Kim. Response rates to medical treatments and long-term clinical outcomes of nonsurgical patients with intestinal Behcet disease. J Clin Gastroenterol 2010; 44: e116-122.

17. 
 SU Kim, KH Han, SH Ahn. Transient elastography in chronic hepatitis B: An Asian perspective. World J Gastroenterol 2010; 41: 5173-5180.

18. 
 SU Kim, HW Jang, JY Cheong, JK Kim, MH Lee, DJ Kim, JM Yang, SW Cho, KS Lee, EH Choi, YN Park, KH Han. The usefulness of liver stiffness measurement using FibroScan in chronic hepatitis C in South Korea: A multicenter, prospective study. J Gastroenterol Hepatol 2010, 26: 171-178.

19.
  SU Kim, YS Seo, JY Cheong, MY Kim, JK Kim, SH Um, SW Cho, SK Paik, KS Lee, KH Han, SH Ahn. Factors that affect the diagnostic accuracy of liver fibrosis measurement by Fiborscan in patients with chronic hepatitis B. Aliment Pharmacol Ther 2010; 32: 498-505.

20.
 YE Chon, SU Kim (Co-primary), CK Lee, J Heo, JK Kim, KT Yoon, M Cho, KS Lee, DH Kim, EH Choi, JY Park, DY Kim, CY Chon, KH Han, SH Ahn. Partial virological response to entecavir in treatment-naïve patients with chronic hepatitis B. Antiviral Ther 2011; 16: 469-477.

21.
 YE Chon, SU Kim (Co-primary), CK Lee, JY Park, DY Kim, KH Han, CY Chon, SY Kim, KS Jung, SH Ahn. Community-acquired versus nosocominal spontaneous bacterial peritonitis in patients with liver cirrhosis. Hepatogastoenterology 2014; 61: 2283-2290.

22.
 YE Chon, J Seong, BK Kim, J Cha, SU Kim, JY Park, SH Ahn, KH Han, CY Chon, SK Chin, DY Kim. Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: endoscopic findings and risk factors. Int J Radiat Oncol Biol Phys 2011; 81: 1343-1351.

23.
  KS Jung, SU Kim (Co-primary), SH Ahn, YN Park, DY Kim, JY Park, CY Chon, EH Choi, KH Han. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan®). Hepatology 2011; 53: 885-894.

24.
 SH Kim, SB Kim, JG Lee, SU Kim, MS Park, DY Kim, JS Choi, KS Kim. Prognostic factors and 10-year survival in patients with hepatocellular carcinoma after curative hepatectomy. J Gastrointest Surg 2011; 15: 598-607.

25.  HW Jang, SU Kim (Co-primary), JY Park, SH Ahn, KH Han, CY Chon, YN Park, EH Choi, DY Kim. How many valid measurements are necessary to assess liver fibrosis using FibroScan® in patients with chronic viral hepatitis? An analysis of subjects with at least 10 valid measurements. Yonsei Medical Journal 2012; 53: 337-345.

26.  SU Kim, YE Chon, CK Lee, JY Park, DY Kim, KH Han, CY Chon, S Kim, KS Jung, SH Ahn. Spontaneous bacterial peritonitis in patients with hepatitis B virus-related liver cirrhosis: Community-acquired versus nosocomial Yonsei Medical Journal 2012; 53: 328-336.

27. 
 SJ Byun, SU Kim (Co-primary), JY Park, BK Kim, DY Kim, KH Han, CY Chon, SH Ahn. Acute variceal hemorrhage in patients with liver cirrhosis: Weekend versus weekday admissions. Yonsei Medical Journal 2012; 53: 318-327.

28. 
 KT Yoon, SM Lim, JY Park, DY Kim, SH Ahn, KH Han, CY Chon, M Cho, JW Lee, SU Kim (Corresponding). Liver stiffness measurement using acoustic radiation force impulse (ARFI) elastography and effect of necroinflammation. Digestive and Liver Disease 2012; 57: 1682-1691.

29.
 YH Chun, SH Ahn, JY Park, DY Kim, KH Han, CY Chon, SJ Byun, SU Kim (Corresponding). Clinical characteristics and treatment outcomes of hepatocellular carcinoma with inferior vena cava/heart invasion. Anticancer Research 2011; 31: 4641-4646.

30. 
 BK Kim, SU Kim (Co-primary), GH Choi, WK Han, MS Park, EH Kim, JY Park, DY Kim, JS Choi, SC Yang, EH Choi, K Song, SH Ahn, KH Han, CY Chon. The “normal” liver stiffness values differ between men and women: A prospective study for healthy living liver and kidney donors in a native Korean population. Journal of Gastroenterology and Hepatology 2012; 27: 781-788.

31. 
 DY Kim, SH Ahn, SU Kim, SB Choi, KH Lee, MS Park, JY Park, DY Lee, KH Han, KS Kim. Adjuvant hepatic arterial infusional chemotherapy with 5-fluorouracil and cisplatin after curative resection of hepatocellular carcinoma. Oncology 2011; 81: 184-191.

32. 
 MH Lee, DY Kim, JK Kim, HY Chang, SH Kang, HJ Ryu, HL Ju, SU Kim, JM Lee, JY Park, KH Han, CY Chon, SH Ahn. Combination of preS deletions and A1762T/F1764A mutations in HBV subgenotype C2 increased the risk of developing HCC. Intervirology 2012; 55: 296-302.

33. 
 YH Chon, SU Kim (Co-primary), JY Park, DY Kim, KH Han, CY Chon, BK Kim, GH Choi, KS Kim, JS Choi, SH Ahn. Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma. European Journal of Cancer 2011; 47: 2568-2575.

34.
   MH Lee, SU Kim (Co-primary), DY Kim, SH Ahn, EH Choi, KH Lee, DY Lee, J Seong, KH Han, CY Chon, JU Park. Early-on-treatment predictions of clinical outcomes using alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with advanced hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2012; 27: 313-322.

35. 
 CY Son, SU Kim (Corresponding), WK Han, GH Choi, H Park, SC Yang, JS Choi, JY Park, DY Kim, SH Ahn, CY Chon, KH Han. Normal liver elasticity values using acoustic radiation force impulse imaging: a prospective study in healthy living and kidney donors. Journal of Gastroenterology and Hepatology 2012; 27: 130-136.

36. 
 DY Kim, JW Choi, HY Chang, SU Kim, H Park, YH Paik, JK Kim, SH Ahn, JY Park, SI Chung, KS Lee, KH Han, CY Chon. Toll-like receptor polymorphisms are not associated with liver cirrhosis in hepatitis B virus infected Korean patients. Hepatogastroenterology 2010; 57” 1351-1355. 

37. 
 SU Kim, JK Kim, YN Park, KH Han. Discordance between liver biopsy and FibroScan® in assessing liver fibrosis in chronic hepatitis B: risk factors and influence of necroinflammation. PloS One 2012; 7: e32233.

38.
 YE Chon, GH Choi, MH Lee, SU Kim, DY Kim, SH Ahn, KS Kim, JS Choi, KH Han, CY Chon, JY Park. Combined measurement of preoperative alpha-fetoprotein and des-gamma-carboxyprothrombin predicts recurrence after curative resection in patients with hepatitis-B related hepatocellular carcinoma. International Journal of Cancer 2012; 131: 2332-2341.

39.
HS Shin, SU Kim (Co-primary), JY Park, DY Kim, KH Han, CY Chon, Oidov B, SH Ahn. Antiviral efficacy of lamivudine versus entecavir in patients with hepatitis B virus-related advanced hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2012; 27: 1528-1534.

40.
BK Kim, SU Kim (Co-primary), JY Park, DY Kim, SH Ahn, J Seong, DY Lee, KH Han. Applicability of BLCL stage for prognostic stratification in comparison with other staging systems; single center experience from long-term clinical outcomes of 1,717 treatment-naïve patients with hepatocellular carcinoma. Liver International 2012; 32: 1120-1127.

41.
JH Seo, SU Kim (Co-primary), JY Park, DY Kim, KH Han, CY Chon, SH Ahn. Predictors of refractory ascites development in patients with hepatitis B virus-related cirrhosis hospitalized to control ascitic decompensation. Yonsei Medical Journal 2013: 54: 145-153.

42.
BK Kim, SU Kim (Co-primary), JY Park, SH Ahn, CY Chon, YN Park, KH Han, DY Kim. Prospective validation of FibroTest in comparison with liver stiffness using transient elastography for predicting liver fibrosis in Asian subjects with chronic hepatitis B. PLos One 2012;7(4):e35825.

43.
SU Kim, JH Lee, DY Kim, SH Ahn, KS Jung, EH Choi, YN Park, KH Han, CY Chon, JY Park. Prediction of liver-related events using FibroScan® in chronic hepatitis B patients showing advanced liver fibrosis. PLoS One 2012;7(5):e36676.

44.
H Park, SU Kim (Co-primary), DY Kim, SH Ahn, KH Han, CY Chon, JY Park. Optimal time for restoring the reliability of liver stiffness measurement in patients with chronic hepatitis B experiencing acute exacerbation. Journal of Clinical Gastroenterology 2012; 46: 602-607.

45.
SU Kim, HJ Oh, Ian RW, S Lee, KH Han, YN Park. Histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis. Journal of Hepatology 2012; 57: 556-563.

46.
SH Kang, DY Kim, SM Jeon, SH Ahn, JY Park, SU Kim, JK Kim, KS Lee, CY Chon, KH Han. Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels. European Journal of Gastroenterology and Hepatology 2012; 24: 849-856.

47.
YE Chon, ES Jung, JY Park, DY Kim, SH Ahn, KH Han, CY Chon, KS Jung, SU Kim (Corresponding). The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B. Journal of Clinical Gastroenterology. 2012; 46: 518-525.

48.
KS Jung, SU Kim (Co-primary), GH Choi, JY Park, YN Park, DY Kim, SH Ahn, CY Chon, KS Kim, EH Choi, JS Choi, KH Han. Prediction of recurrence after curative resection of hepatocellular carcinoma using liver stiffness measurement (FibroScan®). Ann Surg Oncol 2012; 19: 4278-4286.

49.
Kim BK, Kim HS, Park JY, Kim do Y, Ahn SH, Chon CY, Han KH, SU Kim (Corresponding). Prospective validation of ELF test in comparison with FibroScan and FibroTest to predict liver fibrosis in Asian subjects with chronic hepatitis B. PLoS One 2012; 7: e41964

50.
Kim BK, Kim KA, Park JY, Ahn SH, Chon CY, Han KH, Kim SU (Co-corresponding), Kim MJ. Prospective comparison of prognostic values of modified Response Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolization. Eur J Cancer 2013; 49: 826-834.

51.
Chon YE, Choi EH, Song KJ, Park JY, Kim DY, Han KH, Chon CY, Ahn SH, Kim SU (Co-corresponding). Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: A meta-analysis. PLoS One 2012; 7: e44930.

52.
MS Park, SU Kim (Co-primary), JY Park, DY Kim, SH Ahn, KH Han, CY Chon, J Seong. Combination treatment of localized concurrent chemoradiation therapy and transarterial chemoembolization in locally advanced hepatocellular carcinoma with intrahepatic metastasis. Cancer Chemother Pharmacol 2013; 71: 165-173.

53.
SW Lee, HJ Park, BK Kim, KH Han, SK Lee, SU Kim (Co-corresponding), YB Park. Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate. Arthritis Res Ther 2012; 14: R232.

54.
Kim BK, Kim SU (Corresponding),.Kim MJ, Kim KA, Kim DY, Par JY, Ahn SH, Han KH, Chon CY. Number of target lesions for EASL and modified RECIST to predict survivals in hepatocellular carcinoma treated with chemoembolization. Clin Cancer Res 2013; 19: 1503-11.

55.
YK Lee, SU Kim (Co-primary), DY Kim, SH Ahn, KH Lee, DY Lee, KH Han, CY Chon, JY Park. Prognostic value of alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization. BMC cancer 2013; 13: 5.

56.
SH Han, SU Kim (Co-primary), CO Kim, SJ Jeong, JY Park, JY Choi, DY Kim, SH Ahn, YG Song, KH Han, JM Kim. Abnormal liver stiffness assessed using transient elastography (FibroScan®) in HIV-infected patients without HBV/HCV coinfection receiving combined antiretroviral treatment. PLoS One 2013; 8(1): e52720.

57.
BK Kim, HJ Oh, JY Park, DY Kim, SH Ahn, KH Han, Y Park, YN Park, SU Kim (Corresponding). Early on-treatment change in liver stiffness predicts development of liver-related events in chronic hepatitis B patients receiving antiviral therapy. Liver Int. 2013; 32: 180-189.

58.
MS Park, BK Kim, JY Cheong, DJ Kim, JY Park, DY Kim, SH Ahn, KH Han, CY Chon, SU Kim (Corresponding). Discordance between liver biopsy and FibroTest in assessing liver fibrosis in chronic hepatitis B. PLoS One. 2013; 8(2): e55759.

59.
H Park, JY Park, DY Kim, SH Ahn, CY Chon, KH Han, SU Kim (Corresponding). Characterization of focal liver masses using acoustic radiation force impulse elastography. World J Gastroenterol 2013; 19: 219-226.

60.
Y Park, SU Kim (Corresponding), MJ Koh, S Lee. Compensated heart failure does not always alleviate overestimation of liver stiffness by transient elastography. Eur J Gastroenterol 2013; 25: 385-2873

61.
EJ Yoo, BK Kim, SU Kim (Corresponding), JY Park, DY Kim, SH Ahn, KH Han, CY Chon, HS Kim. Normal enhanced liver fibrosis (ELF) values in apparently healthy subjects undergoing a health check-up and in in living liver donors in South Korea. Liver Int; 2013; 33: 706-713.

62.
MS Park, BK Kim, KS Kim, JK Kim, SU Kim, JY Park, DY Kim, O Baartarkhuu, KH Han, CY Chon. Antiviral efficacies of currently available rescue therapies for multidrug-resistant chronic hepatitis B. Clin Mol Hepatol. 2013; 19: 29-35.

63.
JY Jang, MY Kim, SW Jeong, TY Kim, SU Kim, SH Lee, KT Suk, SY Park, HY Woo, SG Kim, J Heo, SK Baik, HS Kim, WY Tak. Current consensus and guideline of contrast enhanced ultrasound for the characterization of focal liver lesions. Clin Mol Hepatol. 3013; 19: 1-16.

64.
DH Han, GH Choi, KS Kim, JS Choi, YN Park, SU Kim, JY Park, SH Ahn, KH Han. The prognostic significance of the worst grade in hepatocellular carcinoma with heterogeneous histologic grades of differentiation. J Gastroenterol Hepatol. 2013; 28: 1384-90.

65.
SH Choi, GH Choi, SU Kim, JU Park, DJ Joo, MK Ju, MS Kim, JS Choi. KH Han. SI Kim. Role of surgical resection for multiple hepatocellular carcinomas. World J Gastoenterol. 2013; 21: 366-374.

66.
KH Han, DY Kim, JY Park, SH Ahn, J Kim, SU Kim, JK Kim, KS Lee, CY Chon. Survival of hepatocellular carcinoma patients may be improved in surveillance interval nor more than 6 months compared with more than 6 months: A 15-year prospective study. J Clin Gastroenterol 2013; 47:538-44.

67.
SH Kim, DY Kim, JK Lim, SU Kim, CH Choi, SH Ahn, JS Choi, KS Kim. Role of splenectomy in patients with hepatocellular carcinoma and hypersplenism. ANZ J Surg 2013; 83: 865-70.

68.
YE Chon, JY Park, SH Ahn, DY Kim, HK Han, CY Chon, A Choi, SU Kim (Corresponding). Partial virological response to adefovir add-on lamivudine rescue therapy in patients with lamivudine-resistant chronic hepatitis B. Digestion 2013; 87: 196-203.

69.
DY Kim, HY Chang, SM Lim, SU Kim, JY Park, JK Kim, KS Lee, KH Han, CY Chon, SH Ahn. Quasispecies and pre-existing drug-resistant mutations of hepatitis B virus in patients with chronic hepatitis B. Gut Liver 2013; 7: 329-334.

70.
MN Kim, SU Kim (Co-primary), JY Park, DY Kim, KH Han, CY Chon, SH Ahn. Risk assessment of liver-related events using transient elastography in patients with chronic hepatitis B receiving entecavir. J Clin Gastoenterol 2014;48:272-278.

71.
EJ Yoo, HS Shin, SU Kim (Corresponding), DJ Joo, JY Park, GH Choi, DY Kim, SH Ahn, J Soeng, MJ Koh, KH Han, CY Chon. Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma. Onco Targets Ther 2013; 6: 755-759.

72.
YE Chon, KS Jung, SU Kim (Co-corresponding), JY Park, YN Park, DY Kim, SH Ahn, CY Chon, HW Lee, Y Park, KH Han. Controlled attenuation parameter (CAP for detection of hepatic steatosis in patients with chronic liver disease: a prospective study of a native Korean population. Liver Int 2014;34:102-109.

73.
H Park, SU Kim, JU Park, DY Kim, SH Ahn, CY Chon, KH Han, J Seong. Clinical usefulness of double biomarkers AFP and PIVKA-II for subdividing prognostic groups in locally advanced hepatocellular carcinoma. Liver Int 2014; 34: 313-21.

74.
SU Kim (Co-primary), KJ Song, HY Chang, EC Shin, JY Park, DY Kim, KH Han, CY Chon, SH Ahn. Association between IL28B polymorphisms and spontaneous clearance of hepatitis B virus infection. PLoS One 2013; 17; 8(7):e69166.

75.
DY Kim, KJ Song, SU Kim (Corresponding), EJ Yoo, JY Park, SH Ahn, KH Han. Transient elastography-based risk estimation of hepatitis B virus-related occurrence of hepatocellular carcinoma: development and validation of a predictive model. Onco Targets Ther. 2013; 6: 1463-1469.

76. S Lee, BK Kim, SU Kim (Corresponding), Y Park, S Chang, JY Park, DY Kim, SH Ahn, HK Han. Efficacy of sorafenib monotherapy versus sorafenib-based loco-regional treatments in advanced hepatocellular carcinoma. PLoS One. 2013; 8: e77240.

77. W Kang, SU Kim (Corresponding). Chasing after novel non-invasive markers to identify advanced fibrosis in NAFLD. Clin Mol Hepatol 2013; 19: 255-257.

78. JY Jang, MY Kim, SW Jeong, TY Kim, SU Kim, SH Kim, SH Lee, KT Suk, SY Park, HY Woo, SG Kim, J Heo, SK Baik, HS Kim, WY Tak. Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions. Clin Mol Hepaol 2013; 19: 1-16.

79. YE Chon, SU Kim (Co-primary), JY Park, DY Kim, SH Ahn, KH Han, CY Chon, S Lee. Dynamics of the liver stiffness value using transient elastography during the perioperative period in patients with valvular heart disease. PLoS One 2014 26;9:e92795.

80. W Kang, SU Kim (Co-primary), SH Ahn. Non-invasive prediction of forthcoming cirrhosis-related complications. World J Gastroenterol 2014;20:2513-2623.

81. SU Kim (Co-primary), Jung KS, Lee S, Park JY, Kim DY, Ahn SH, Choi GH, Kim KS, Choi JS, Han KH, Park YN. Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma. Liver Int 2014; 34: 1008-17.

82. MN Kim, SU Kim (Corresponding), BK Kim, JY Park, DY Kim, SH Ahn, KH Han. Long-term changes of liver stiffness values assessed using transient elastography in patients with chronic hepatitis B receiving entecavir. Liver Int 2014; 34: 1216-23.

83. Shin SH, Kim SU (Co-first), Park JY, Kim DY, Ahn SH, Han KH, Kim BK. Liver stiffness-based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection; comparison with histological fibrosis. Liver Int 2014; 35: 1054-62.

84. Jung KS, Kim JH, Kim SU (Corresponding), Song K, Kim BK, Park JY, Kim DY, Ahn SH, Moon DC, Song IJ, Choi GH, Park YN, Han KH. Liver stiffness value-based risk estimation of late recurrence after curative resection of hepatocellular carcinoma: development and validation of a predictive model. PLoS One 2014;9:e99167.

85. Jung KS, Kim BK, Kim SU (Corresponding), Chon YE, Cheon KH, Kim SB, Lee SH, Ahn SS, Park JY, Kim DY, Ahn SH, Park YN, Han KH. Factors affecting the accuracy of controlled attenuation parameter (CAP) in assessing hepatic steatosis in patients with chronic liver disease. PLoS One 2014;9:e98689.

86. Yoo BW, Choi JY, Eun LY, Park HK, Park YH, Kim SU (Co-corresponding). Congestive hepatopathy after Fontan operation and related factors assessed by transient elastography. J Thorac Cardiovasc Surg 2014; 148: 1498-505.

87. Kim BK, Kim HS, Yoo EJ, Park JY, Kim DY, Ahn SH, Han KH, Park YN, Kim SU (Co-corresponding). Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test. Hepatology 2014; 60: 1911-9.

88.  Chon YE, Jung KS, Kim KJ, Joo DJ, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Kim SU (Corresponding). Normal controlled attenuation parameter value: A prospective study of healthy subjects undergoing health checkups and liver donors in Korea. Dig Dis Sci 2015; 60: 234-42.

89. HW Lee, EJ Yoo, BK Kim, SU Kim (Co-corresponding), JY Park, DY Kim, SH Ahn, KH Han. Prediction of development of liver-related events by transient elastography in hepatitis B patients with complete virological response on antiviral therapy. Am J Gastoenterol 2014; 109: 1241-9.

90. S Lee, BK Kim, SU Kim (Co-corresponding), SY Park, JK Kim, HW Lee, JY Park, DY Kim, SH Ahn, WY Tak, YO Kweon, JI Lee, KS Lee, JH Kim, KH Han. Clinical outcomes and prognostic factors of patients with advanced hepatocellular carcinoma treated with sorafenib as first-line therapy: A Korean multicenter study. J Gastroenterol Hepatol 2014; 29: 1463-1469.

91. Lee SH, Kim SU (Co-corresponding), Jang JW, Bae SH, Lee S, Kim BK, Park JY, Kim DY, Ahn SH, Han KH. Use of transient elatography to predict de novo recurrence after radiofrequency ablation for hepatocellular carcinoma. Onco Targets Ther 2015; 8: 437-356

92. Kim MN, Kim SU (Co-corresponding), Kim BK, Park JY, Kim DY, Ahn SH, Song KJ, Park YN, Han KH. Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis. Hepatology 2015 2015; 61: 1851-1959

93. Kim BK, Kim SU (Corresponding), Kim KA, Chung YE, Kim MJ, Park MS, Park JY, Kim DY, Ahn SH, Kim MD, Park SI, Won JY, Lee DY, Han KH. Complete response at the first chemoembolization is still the robust predictor for favorable outcome in hepatocellular carcinoma. J Hepatol 2015 2015; 62: 1304-1310.

94. Yoo SC, Kim KJ, Kim SU (Corresponding), Kim BK, Park JY, Kim DY, Ahn SH, Lee WJ, Han KH. Factors associated with significant liver fibrosis assessed using transient elastography in general population. World J Gastroenterol 2015; 21: 1158-1166.

95. Wong WV, Lampertico P, de Ledinghen V, Chang PE, Kim SU, Chen Y, Chan HL, Mangia G, Foucher K, Chow WC, Ahn SH, Hou J. Probability-based interpretation of liver stiffness measurement in untreated chronic hepatitis B patients. Dig Dis Sci. 2015; 60: 1448-1456.

96. Kim BK, Kim KA, Ahn C, Yoo EJ, Park JY, Kim DY, Ahn SH, Han KH, Kim SU (Co-corresponding), Kim MJ. Prognostic role of magnetic resonance imaging vs. computed tomography for hepatocellular carcinoma undergoing chemoembolization. Liver Int 2015; 35: 1722-1730.

97. Park MS, Kim SU (Co-primary), Kim BK, Park JY, Kim DY, Ahn SH, Shin SH, Kang W, Moon C, Han KH. Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B. Liver Int 2015; 35: 455-462.

98. Chon YE, Kim SU (co-primary), Lee CK, Park JY, Kim DY, Han KH, Chon JY, Kim S, Jung KS, Ahn SH. Community-acquired vs. nosocomial spontaneous bacterial peritonitis in patients with liver cirrhosis. Hepatogastroenteroloy. 2015; 61: 2283-2290.

99. Park Y, Kim SU (Co-corresponding), Park SY, Kim BK, Park JY, Kim DY, Ahn SH, Tak WY, Kweon YO, Han KH. A novel model to predict esophageal varices in patients with compensated cirrhosis using acoustic radiation force impulse elastography. PLoS One 31:10:e0101009

100.  Lee YH, Jung KS, Kim SU, Yoon HJ, Yun YJ, Lee BW, Kang ES, Han KH, Cha BS. Sarcopenia is associated with NAFLD independently of obesity and insulin resistance: nationwide surveys (KNHANES 2008-2011). J Hepatol [in press]
101.  Ahn SS, Kim EH, Kim MD, Lee WJ, Kim SU (Corresponding). Successful hemostasis of intractable rectal variceal bleeding using variceal embolization. World J Gastroenterol 21; 21: 2558-2562.

102.  Seo YS, Kim MY, Kim SU (co-corresponding), Hyun BS, Jang JY, Lee JW, Lee JI, Suh SJ, Park SY, Park H, Jung EU, Kim BS, Kim IH, Lee TH, Um SH, Han KH, Kim SG, Paik SK, Choi JY, Jeong SW, Jin YJ, Lee KS, Yim HJ, Tak WY, Hwang SG, Lee YJ, Lee CH, Kim DG, Kang YW, Kim YS: The Korean Transient Elastography Study Group. Liver Int [in press]

103.
  Park MS, Kim SW, Yoon KT, Kim SU, Park SY, Tak WY, Kweon YO, Cho M, Kim BK, Park JY, Kim DY, Ahn SH, Han KH. Factors influencing the diagnostic accuracy of acoustic radiation force impulse elastography in patients with chronic hepatitis B. Gut Liver [in press]

104.  Park Y, Kim SU (Corresponding), Kim BK, Park JY, Kim DY, Ahn SH, Park YE, Park JH, Lee YI, Yun HR, Han KH. Addition of tumor multiplicity improves the prognostic performance of the hepatoma arterial-embolization prognostic score. Liver Int [in press].

105.  Kim MN, Han KH, Kim SU (Corresponding). Reply to “Patients with chronic hepatitis b should be screened for hepatocellular carcinoma regardless of liver stiffness measurement.” Hepatology [in press].

106.  Kim BK, Kim KA, Kim MJ, Park JY, Kim DY, Ahn SH, Han KH, Kim SU (Co-corresponding), Park MS. Inter-observer variability of response evaluation criteria for hepatocellular carcinoma treated with chemoembolization. Dig Liver Dis. [in press]

107.  You SC, Kim KJ, Kim SU (Co-corresponding), Kim BK, Park JY, Kim DY, Ahn SH, Han KH. Hepatic fibrosis assessed using transient elastography in independently associated with coronary artery calcification. J Gastroenterol Hepatol [in press]

108.  Lee HW, Kang W, Kim BK, Kim SU (Corresponding), Park JY, Kim DY, Ahn SH, Park YN, Han KH. Red cell volume distribution width-to-platelet ratio in assessment of liver fibrosis in patients with chronic hepatitis B. Liver Int [in press].

109.
  Kim BK, Shim JH, Kim SU (Co-corresponding), Park JY, Kim DY, Ahn SH, Kim KM, Lim YS, Han KH, Lee HC. Risk prediction for patients with hepatocellular carcinoma undergoing chemoembolization: development of a prediction model. Liver Int [in press].

110.
  Kim BK, Kim SU (Corresponding). Reply to ‘The problem of the most appropriate curative treatment for hepatocellular carcinoma. When to embolize? When to operate?”. J Hepatol 2015; 63: 281-282.

111.
  Lee YH, Kim SU (Corresponding), Song K, Park JY, Kim DY, Ahn SH, Lee BW, Kang ES, Cha BS, Han KH. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011). Hepatology [in press].

112.
  Lee SW, Kim BK, Park JY, Kim DY, Ahn SH, Song J, Park YB, Lee SK, Han KH, Kim SU (Corresponding). Clinical predictors of silent but substantial liver fibrosis in primary Sjogren’s syndrome. Mod Rheumatol [in press].

113.
  Lee S, Park JY, Kim DY, Kim BK, Kim SU, Song K, Ku HJ, Han KH, Ahn SH. Prediction of virologic response to tenofovir mono-therapy for multidrug resistant chronic hepatitis B. J Med Virol [in press].

114.
    Lee S, Kim BK, Song K, Park JY, Ahn SH, Kim SU, Han KH. Sub-classification of Barcelona Clinic Liver Cancer B and C hepatocellular carcinoma: A cohort study of the multi-center registry database. J Gastroenterol Hepatol [in press].

115.
  Choi SH, Park JY, Kang W, Kim SU, Kim DY, Ahn SH, Ro SW, Han KH. Knockdown of HIF-1α and IL-8 induced apoptosis of hepatocellular carcinoma triggers apoptosis of vascular endothelial cells. Apoptosis [in press].

116.
  Chung H, Chon YE, Kim SU (Co-corresponding), Lee SK, Jung KS, Han KH, Chon CY. Noninvasive prediction of erosive esophagitis using a controlled attenuation parameter (CAP)-based risk estimation model. Dig Dis Sci [in press].

117.
  Lee J, Oh YT, Joo DJ, Ma BG, Lee AL, Lee JG, Song SH, Kim SU, Jung DC, Chung YE, Kim YS. Acoustic radiation force impulse measurement in renal transplantation: A prospective, longitudinal study with protocol biopsies. Medicine (Baltimore) [in press].

118.
  Kim YD, Song D, Heo JH, Kim SU (Co-corresponding), Kim BK, Park JY, Kim DY, Ahn SH, Kim KJ, Han KH. Relationship between cerebral microbleeds and liver stiffness determined by transient elastography. PLoS One 2015; 30;10(9):e0139227.

119.
  Lee HW, Chon YE, Kim SU (Co-corresponding), Kim BK, Park JY, Kim DY, Ahn SH, Jung KS, Park YN, Han KH. Predicting liver-related events using transient elastography in chronic hepatitis C patients with sustained virological response. Gut Liver 2015 [in press].

120.
  Lim TS, Kim DY, Han KH, Kim HS, Shin SH, Jung KS, Kim BK, Kim SU, Park JY, Ahn SH. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients. Scand J Gastroenterol 2016; 51: 344-353.

121.
  Kim SU, Park JH, Kim HS, Lee JM, Lee HG, Kim H, Choi SH, Baek S, Kim BK, Park JY, Kim DY, Ahn SH, Lee JD, Han KH. Serum Dickkopf-1 as a biomarker for the diagnosis of hepatocellular carcinoma. Yonsei Med J. 2015; 56: 1296-1306.

122.
  Jung KS, Kim SU, Song K, Park JY, Kim DY, Ahn SH, Kim BK, Han KH. Validation of hepatitis B virus-related hepatocellular carcinoma prediction models in the era of antiviral therapy. Hepatology [in press].

123.
  Lee SW, Kim BK, Park JY, Kim DY, Ahn SH, Song JJ, Park YB, Lee SK, Han KH, Kim SU (Corresponding). Disease duration and Medsger’s severity score are associated with significant liver fibrosis in patients with systemic sclerosis. Clin Exp Rheumatol 2015; 33: S68-74.

124.
  Kim SB, Kim SU (Corresponding), Kim BK, Park JY, Kim DY, Ahn SH, Han KH. Outcome of adefovir add-on lamivudine rescue therapy of up to 5 years in patients with lamivudine-resistant chronic hepatitis B. J  astroenterol Hepatol 2015 [in press].

125. Park Y, Kim SU (Corresponding). Reply to ‘prognostic model for patients receiving arterial-embolization for hepatocellular carcinoma: issues to consider’. Liver Int [in press].


126. Park Y, Kim SU (Corresponding). Reply to ‘prognostic model for patients receiving arterial-embolization for hepatocellular carcinoma: issues to consider’. Liver Int. 2016 Feb;36(2):312.


127.  Jung KS, Park JY, Chon YE, Kim HS, Kang W, Kim BK, Kim SU, Kim DY, Han KH, Ahn SH. Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients. J Gastroenterol. 2016 Aug;51(8):830-9.


128..  Lee HK, Park JJ, Kim SU (Co-corresponding), Lee JE, Leem GL, Kim T, Kim BK, Park JY, Kim DY, Ahn SH, Han KH. Incidence and risk factors of delayed postpoylectomy bleeding in patients with chronic liver disease. Scand J Gastroenterol 2016; 51: 618-624.


129.  Lee HW, Park SY, Kim SU (Co-corresponding), Jang JY, Park H, Kim JK, Lee CK, Chon YE, Han KH. Discrimination of nonalcoholic steatohepatitis using transient elastography in patients with nonalcoholic fatty liver disease. PLoS One 2016; 11: e0157358.


130.  Lee HG, Kim H, Son T, Jeong Y, Kim SU, Dong SM, Park YN, Lee JD, Lee JM, Park JH. Regulation of HK2 expression through alterations in CpG methylation of the HK2 promoter during progression of hepatocellular carcinoma. Oncotarget. 2016 Jul 5;7(27):41798-41810.


131.  Kim GM, Won JY, Kim MD, Park SI, Lee DY, Shin W, Shin M, Han KH, Kim DY, Kim SU. Cryoablation of hepatocellular carcinoma with high-risk for percutaneous ablation: safety and efficacy. Cardiovasc Intervent Radiol. 2016 Oct;39(10):1447-54.


132.  Lee S, Kim KM, Lee SJ, Lee KH, Lee DY, Kim MD, Kim DY, Kim SU, Won JY. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study. Acta Radiol. 2017 Feb;58(2):131-139.


133.  Yim SY, Lee JH, Ahn H, Kim SU, Kim SG, Kim YS, Kim JH, Choe WH, Kim TY, Jung YK, Suh SJ, Suk KT, An H, Yim HJ, Seo YS, Um SH. Subclinical ascites does not affect the long-term prognosis in hepatitis B virus-related cirrhosis patients receiving antivirals. J Clin Gastroenterol. 2016 Sep;50(8):676-85.


134.  Kim SU, Kim BK, Park JY, Kim DY, Ahn SH, Song K, Han KH. Transient elastography is superior to FIB-4 in assessing the risk of hepatocellular carcinoma in patients with chronic hepatitis B. Medicine 2016; 95: e3434.

135.  Lee JM, Seo YS, Kim TH, Ahn JM, Yim SY, Kim SU (Co-corresponding), Jung YK, Kim JK, Ah H, Yim HJ, Yeon JE, Lee HK, Byun KS, Um SH, Kim CH, Ryu HS. The LAW index as an accurate indicator of the initiation of antiviral treatment in patients with chronic hepatitis B. J Gastroenterol Hepatol. 2017 Jan;32(1):208-214.



136. 
Chon YE, Kim KJ, Jung KH, Kim SU, Park JY, Kim DY, Ahn SH, Chon CY, Chung JB, Park KH, Bae JC, Han KH. The relationship between type 2 diabetes mellitus and nonalcoholic fatty liver disease measured by controlled attenuation parameter. Yonsei Med J 2016; 57: 885-892.

137.  Heo JY, Kim SU (Co-corresponding), Kim BK, Park JY, Kim DY, Ahn SH, Park YN, Ahn SS, Han KH, Kim HS. Use of Wisteria Floribunda Agglutinin-positive human MAC-2 binding protein in assessing risk of hepatocellular carcinoma due to hepatitis B virus. Medicine (Baltimore). 2016 Apr;95(14):e3328.

138.  Lee HS, Park JJ, Kim SU (Co-corresponding), Lee JE, Leem GL, Kim Y, Kim BK, Park JY, Kim DY, Ahn SH, Han KH. Incidence and risk factors of delayed polypectomy bleeding in patients with chronic liver disease. Scand J Gastroenterol 2016; 51: 618-624.

139.  Kim HS, Kim BK, Kim SU (Co-corresponding), Park JY, Kim DY, Song KJ, Park JW, Kim YJ, Baatarkhuu O, Han KH, Ahn SH. Association between level of fibrosis, rather than antiviral regimen, and outcomes of patients with chronic hepatitis B. Clin Gastroenterol Hepatol. 2016 Nov;14(11):1647-1656.e6.

140.  Park YE, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Han S, Jeon MY, Heo JY, Song K, Kim SU (Correponding). Gamma-glutamyl transpeptidase-to-platelet ratio is an independent predictor of hepatitis B virus-related liver cancer. J Gastroenterol Hepatol. 2017;32:1221-1229.

141.  
Lee YR, Park SY, Kim SU (Co-corresponding), Jang SY, Tak WY, Kweon YO, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Hur K. Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablation. J Gastroenterol Hepatol. 2017;32:1079-1086.

142.  Kim SU, Heo JY, Kim BK, Park JY, Kim DY, Han KH, Ahn SH, Kim HS. Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer development. Liver Int. 2017;37:879-887.

143.  Lee SJ, Kim SU (Co-first),  Kim MD, Kim YH, Kim GM, Park SI, Won JY, Lee DY, Lee KH. Comparison of treatment outcomes between balloon-occluded retrograde transvenous obliteration and transjugular intrahepatic portosystemic shunt for gastric variceal bleeding hemostasis. J Gastroenterol Hepatol. 2017;32:1487-1494

144.  Kim SU, Song D, Heo JH, Yoo J, Kim BK, Park JY, Kim DY, Ahn SH, Kim KJ, Han KH, Kim YD. Liver fibrosis assessed with transient elastography is an independent risk factor for ischemic stroke. Atherosclerosis. 2017;260:156-162.

145. Jeon MY, Lee HW, Kim SU (Corresponding), Heo JY, Han S, Kim BK, Park JY, Kim DY, Ahn SH, Han KH. Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis. Hepatol Int 2017; 11: 268-276.

146. Kim MN, Hwang SG, Rim KS, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Kim SU (Corresponding). Validation of PAGE-B Model in Asian Chronic Hepatitis B Patients Receiving Entecavir or Tenofovir. Liver Int. 2017 Apr 18. doi: 10.1111/liv.13450. [Epub ahead of print]

147.  Kim BS, Seo YS, Kim YS, Lee CH, Lee HA, Ho US, Yoo JJ, Kim SG, Suh SJ, Jung YK, Ahn SH, Han KH, Yim HJ, Kim SU (Co-corresponding); Korean Transient Elastography Study Group. Reduced risk of hepatocellular carcinoma by achieving a subcirrhotic liver stiffness through antiviral agents in hepatitis B virus-related advanced fibrosis or cirrhosis. J Gastroenterol Hepatol 2017 [Epub]


[Domestic, Korean]

1.
     SU Kim, YR Kim, DY Kim, JK Kim, HW Lee, BK Kim, YH Paik, KS Lee, KH Han, CY Chon, YM Moon, SH Ahn. The clinical features and treatment outcome of advanced hepatocellular carcinoma with inferior vena caval invasion or atrial tumor thrombus. The Korean Journal of Hepatology 2007; 13: 387-395.

2.
     HJ Choi, SY Ko, WH Choe, YS Seo, JK Kim, KS Byun, YS Kima, SU Kim, SK Baik, JY Cheong, TY Kim, OS Kwon, JH Kim, CH Lee, SY Kwon. Clinical features of acute viral hepatitis B in Korea: a multi-center study. Korean J Hepatol 2011; 17: 307-3012



2011/02/21 15:37 2011/02/21 15:37

댓글을 달아 주세요

1  ... 34 35 36 37 38 

카테고리

전체 (38)
프로필 (7)
언론보도 (23)
건강정보 (0)
세브란스병원소식지 (2)
기타 (3)

공지사항

달력

«   2019/10   »
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

Archive